Swedish Life Sciences Trend Analysis 2016
In 2015 we saw a continuation of the downward trend when it comes to the number of new Biotech companies in Sweden. Also, the value of venture funds invested in the industry dropped dramatically and was about seven times smaller than in 2014. It changed, however, in the first half of 2016, when Aprea Ab raised USD 51m.
Looking for your next Biotech or Medtech partner?
Use Biotechgate to identify new leads, licensing opportunities and management details.